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Letters to the
Editor
Spondyloarthropathies and aortic
dissection
To the Editor:
I have read with great interest the 2 de-
scriptions of Takagi and colleagues1,2 about
aortic dissection without Marfan syndrome
in ankylosing spondylitis recently published
in the Journal. I would like to make some
rheumatologic comments and ask some ques-
tions about them.
Ankylosing spondylitis is a prototype
disease of the so-called spondyloarthropa-
thies, which includes other diseases, such
as undifferentiated spondyloarthropathy, pso-
riatic arthritis, and ankylosing spondylitis
related to inflammatory bowel disease. An-
kylosing spondylitis as a definite entity is
easy to diagnose, although at the beginning
of the disease, the symptoms and comple-
mentary explorations cannot be so clear. It
is known that many undifferentiated spon-
dyloarthropathies will progress to ankylos-
ing spondylitis, and the diseases of the
spondyloarthropathy group present symp-
toms and radiologic alterations similar to
those of ankylosing spondylitis.
The criteria used by Takagi and col-
leagues are those of the European Spondyl-
arthropathy Study Group3 because his pa-
tient2 clearly presents with the criteria of
inflammatory spinal pain and alternate
buttock pain and the possible presence of
sacroiliitis. These symptoms are enough
to classify the patient in the undifferenti-
ated spondyloarthropathy group. The ab-
dominal radiography, as we can see in his
study,2 does not show an evident sacroili-
itis, but some spondyloarthropathy-like ra-
diographic alterations (bamboo spine) ap-
pear. There was no association with HLA
B27, and the same occurs in 5% of the
patients affected by ankylosing spondyli-
tis,4 presenting in 20% to 40% of patients
with psoriatic arthritis, 80% to 90% of pa-
tients with the reactive disease, 33% to
75% of patients with ankylosing spondyli-
tis related to inflammatory bowel disease,
and 40% to 80% of patients with undiffer-
entiated spondyloarthropathy. The abdom-
inal radiograph presented in the first pa-
tient1 shows clearly an ankylosis in both
sacroiliac joints, and although this patient
was not associated with HLA B27, the di-
agnosis of ankylosing spondylitis is evi-
dent.
I would like to ask the authors whether
other complementary explorations were prac-
ticed (computed tomography, magnetic reso-
nance imaging, and radionuclide techniques)
to make the diagnosis of sacroiliitis because a
nonconclusive radiograph is presented. HLA
B27 negativity opens the possibility of some
other entity in the spondyloarthropathy
group, such as psoriatic arthritis, reactive ar-
thritis, ankylosing spondylitis related to in-
flammatory bowel disease, or undifferenti-
ated spondyloarthropathy, which present
with less HLA B27. This type of disease
might also present a less radiologic alteration
in sacroiliac articulations and an asymmetry
in the spondyloarthropathies’ typical syndes-
mophytes.5
I do not cast doubt on the ankylosing
spondylitis diagnosis in any patient pre-
sented by Takagi and colleagues, although
the apparently normal sacroiliac joints in the
second patient2 and the absence of HLA
B27 oblige us to reject other spondyloar-
thropathy types. I would be grateful to the
authors if they could discuss whether they
performed some complementary explora-
tions to look for the sacroiliitis and whether
other entities, such as psoriatic arthritis, reac-
tive arthritis, ankylosing spondylitis related to
inflammatory bowel disease, or undiffer-
entiated spondyloarthropathy were rejected.
That possibility would have an enormous
clinical interest because there is not aortic
dissection without Marfan syndrome de-
scriptions in other spondyloarthropathy
types without being an ankylosing spon-
dylitis.
Antonio Juan, MD
Inmaculada Ros, MD
Hospital Son Llatzer
Rheumatology
Palma de Mallorca, Baleares
Spain
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Reply to the Editor:
This letter is to acknowledge the rheuma-
tologic comments and queries by Juna re-
garding our recently published case re-
ports1,2 of aortic dissection without Marfan
syndrome in ankylosing spondylitis. In re-
gard to the second case,2 Juna asked us
whether other complementary explorations,
such as computed tomography scanning,
magnetic resonance imaging, or radionuclide
imaging, were practiced to obtain the diag-
nosis of sacroiliitis. We practiced computed
tomography scanning (Figure 1), not mag-
netic resonance imaging and radionuclide
imaging, which demonstrated relatively
apparent sacroiliitis, not typical ankylosis
in the sacroiliac joints, despite no evident
sacroiliitis on the abdominal radiography in
the figure of the second case report. To be
accurate, however, the diagnosis of the 2
cases might not be ankylosing spondylitis
itself but spondyloarthropathies, which
consist of ankylosing spondylitis, psoriatic
arthritis, reactive arthritis, inflammatory
bowel disease-related arthritis, and undif-
ferentiated spondyloarthropathy, because
the patients met only the European Spon-
dyloarthropathy Study Group criteria3 for
the classification of spondyloarthropathy.
In both cases, the diagnosis of psoriatic
arthritis, reactive arthritis, or inflammatory
bowel disease-related arthritis may be de-
nied because of the absence of psoriasis,
genitourinary or gastrointestinal infection,
or inflammatory bowel disease. Undiffer-
entiated spondyloarthropathy is one of the
probable diagnoses as mentioned by Juna,
because criteria might not be fulfilled for
any specific spondyloarthropathy in the
second patient. Even though the second
case is not ankylosing spondylitis but un-
differentiated spondyloarthropathy, there
have been no cases of aortic dissection in
undifferentiated spondyloarthropathy in the
literature except for our case.
Hisato Takagi, MD, PhD
Seishiro Sekino, MD
Takuya Umemoto, MD, PhD
Department of Cardiovascular Surgery
Shizuoka Medical Center
Shizuoka, Japan
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Implantable cardioverter-defibrillator
after left ventricular reconstruction?
To the Editor:
We read with great interest the article
by O’Neill and coworkers,1 which ad-
dresses an important question: Is implantable
cardioverter-defibrillator (ICD) implantation
indicated after left ventricular reconstruction
(LVR)?
The authors present their large experi-
ence of LVR as a nontransplant surgical
strategy for patients with heart failure, with
a focus on postoperative malignant arrhyth-
mias. Primary end points were all-cause
mortality and appropriate ICD therapies,
and median follow-up was 381 days. In
addition to the LVR, a small proportion of
patients (13%) received a specific antiar-
rhythmic surgical procedure consisting of
cryoablation, about half (46%) underwent a
mitral valve procedure, and most patients
(88%) were revascularized. The main find-
ings were that patients remain at high risk
of ventricular arrhythmias after LVR and
that the arrhythmias occur early postoper-
atively, in two thirds of the cases within 90
days. The authors recommend early ICD
implantation or electrophysiology (EP)–
guided ICD therapy before hospital dis-
charge after LVR.
We have 2 questions regarding the
study by O’Neill and coworkers1: (1) How
many patients had clinical arrhythmias be-
fore surgical intervention? (2) Were EP
studies conducted before surgical interven-
tion in any of the patients?
The answers to these questions are im-
portant to assess the effect of the procedure
per se on the incidence of postoperative
arrhythmias. There is some theoretic or in-
direct evidence that LVR promotes electri-
cal stability in the heart by different mech-
anisms.2Figure 1. Computed tomography of the second case.
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